Marathon Petroleum Corp. (MPC)

Marathon Petroleum shares rose 3.41% in the latest session but remain 18.45% below their 52-week high of $493.98, and they sit below the 50-day average of $422.89 while holding well above the 200-day average of $299.39. The stock is priced at 7.98 times trailing earnings, a steep discount to the Energy sector median of 18.4, and it has beaten EPS estimates in all seven of the most recent reports covered here. The tension for investors is that strong reported results have not translated into a steady climb: the stock fell in the first session after four of its seven most recent reports, including an 8.11% drop after the November 3, 2026 report.

Marathon Petroleum has beaten EPS estimates in every one of the seven recent reports, with the November 3, 2026 result at $26.93 against a $26.00 estimate, a beat of 3.58%. The August 4, 2026 report was a larger beat, at $17.73 against $13.95, or 27.10%, and the May 5, 2026 report came in at $1.65 against $0.75. Despite that record, the share price fell in the first session after four of the seven reports, including an 8.11% decline after the November 3 report and a 4.75% decline after the August 4 report. For investors, the pattern suggests the market has been pricing in strong refining results in advance, so beating the estimate has not reliably lifted the stock.

At a trailing P/E of 7.98, the stock trades at a discount to the Energy sector median P/E of 18.4, and its price-to-sales ratio of 0.63 compares with a sector median of 2.5. The reported earnings per share over the last 12 months were $50.47, and return on equity stands at 60.46% against a sector median of 14.2%. Revenue grew in the latest quarter on a year-on-year basis, by 60.90%, against a sector median of 32.8%. Analysts, however, expect next year's EPS to fall 10.8% from this year's level, so the low multiple reflects a view that current earnings may not hold.

Of the 18 analysts with a current rating, 8 rate the stock buy or strong buy, 9 rate it hold and 1 rates it sell or strong sell. Three months ago, 10 of 19 ratings were buy, so the number of buy ratings has slipped. Recent actions include Piper Sandler and Morgan Stanley keeping Overweight ratings on November 4 and 5, 2026, while Citigroup kept a Neutral rating on October 13, 2026. Insiders sold $16.9M of stock over the last 18 months in 12 sales and made no open-market purchases. Those sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than purchases would.

The base case is that the stock keeps trading in a wide range while the trend structure stays intact. The price remains above the 200-day average, and as long as it holds there the longer trend stays supportive. The near-term picture depends on whether it can reclaim the 20-day EMA at $419.02 and then the 50-day SMA at $422.89, which would repair the mixed trend. Analysts' 12-month targets run from $236.00 to $564.00, with a median of $466.00, which is 15.7% above the price. Analysts expect fiscal 2026 EPS of $68.85 and fiscal 2027 EPS of $61.42, a projected decline of 10.8%, so the earnings path is expected to soften even as the current year is strong. A move back toward the 52-week high would need sustained beats and a clearer read on next year's earnings. A loss of the 200-day average at $299.39 would signal that the longer uptrend had broken, which the analysts' targets do not anticipate.

Support: the 200-day simple moving average at $299.39 is the nearest level below the price and marks the line the longer uptrend has held above. Below it, the 52-week low at $161.93 is the next floor. Resistance: the 20-day exponential moving average at $419.02 is the nearest level above the price, and the 50-day simple moving average at $422.89 sits just beyond it, so the two form a dense resistance band. The 52-week high at $493.98 is the furthest level above the price and the level the stock would need to clear to reach a new high.